The oversight committee of the Cancer Prevention and Research Institute of Texas (CPRIT) approved $63 million in grant allocation Wednesday to help "bring innovative researchers and companies to Texas."
The oversight committee of the Cancer Prevention and Research Institute of Texas (CPRIT) approved $63 million in grant allocation Wednesday to help "bring innovative researchers and companies to Texas."
DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Incoming Orders/Contract23.03.2022 / 10:16 The issuer is solely responsible for the content of this announcement.Berlin, 23 March 2022. Eckert & Ziegler (ISIN DE0005659700, TecDAX) has executed with the Canadian biotech company Alpha-9 Th.
23.03.2022 - DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Incoming Orders/Contract Eckert & Ziegler to Supply Canadian Alpha-9 Theranostics with Lutetium-177 for Clinical Trials 23.03.2022 / 10:16 The issuer is solely responsible . Seite 1
09.02.2022 - DGAP-News: Eckert & Ziegler Strahlen- und Medizintechnik AG / Key word(s): Incoming Orders/Agreement Eckert & Ziegler to Supply Telix with Lutetium-177 for Clinical Trials 09.02.2022 / 07:45 The issuer is solely responsible for the content of . Seite 1